Diagnostic Performance of Ultrasound-Based Risk Stratification Systems for Thyroid Nodules: A Systematic Review and Meta-Analysis
Endocrinology and Metabolism · 28.02.2023 · 38 (1) · 117-128
DOI: 10.3803/enm.2023.1670 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Endocrinology and Metabolism, erschienen am 28.02.2023. Verfasst von Leehi Joo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Korea University Guro Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Thyroid Nodule. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
This study investigated the diagnostic performance of biopsy criteria in four society ultrasonography risk stratification systems (RSSs) for thyroid nodules, including the 2021 Korean (K)-Thyroid Imaging Reporting and Data System (TIRADS).
Methods
The Ovid-MEDLINE, Embase, Cochrane, and KoreaMed databases were searched and a manual search was conducted to identify original articles investigating the diagnostic performance of biopsy criteria for thyroid nodules (≥1 cm) in four widely used society RSSs.
Results
Eleven articles were included. The pooled sensitivity and specificity were 82% (95% confidence interval [CI], 74% to 87%) and 60% (95% CI, 52% to 67%) for the American College of Radiology (ACR)-TIRADS, 89% (95% CI, 85% to 93%) and 34% (95% CI, 26% to 42%) for the American Thyroid Association (ATA) system, 88% (95% CI, 81% to 92%) and 42% (95% CI, 22% to 67%) for the European (EU)-TIRADS, and 96% (95% CI, 94% to 97%) and 21% (95% CI, 17% to 25%) for the 2016 K-TIRADS. The sensitivity and specificity were 76% (95% CI, 74% to 79%) and 50% (95% CI, 49% to 52%) for the 2021 K-TIRADS1.5 (1.5-cm size cut-off for intermediate-suspicion nodules). The pooled unnecessary biopsy rates of the ACR-TIRADS, ATA system, EU-TIRADS, and 2016 K-TIRADS were 41% (95% CI, 32% to 49%), 65% (95% CI, 56% to 74%), 68% (95% CI, 60% to 75%), and 79% (95% CI, 74% to 83%), respectively. The unnecessary biopsy rate was 50% (95% CI, 47% to 53%) for the 2021 K-TIRADS1.5.
Conclusion
The unnecessary biopsy rate of the 2021 K-TIRADS1.5 was substantially lower than that of the 2016 K-TIRADS and comparable to that of the ACR-TIRADS. The 2021 K-TIRADS may help reduce potential harm due to unnecessary biopsies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Korea University Guro Hospital, Seoul, Korea.
- Department of Radiology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea.
- Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Department of Radiology, Ajou University Hospital, Ajou University School of Medicine, Suwon, Korea.
- Department of Radiology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.
Zitieren
APA
Joo, L., Lee, M. K., Lee, J. Y., Ha, E. J., & Na, D. G. (2023). Diagnostic Performance of Ultrasound-Based Risk Stratification Systems for Thyroid Nodules: A Systematic Review and Meta-Analysis. Endocrinology and Metabolism, 38(1), 117-128. https://doi.org/10.3803/enm.2023.1670
Vancouver
Joo L, Lee MK, Lee JY, Ha EJ, Na DG. Diagnostic Performance of Ultrasound-Based Risk Stratification Systems for Thyroid Nodules: A Systematic Review and Meta-Analysis. Endocrinology and Metabolism. 2023;38(1):117-128. doi:10.3803/enm.2023.1670
BibTeX
@article{Joo2023,
author = {Joo, Leehi and Lee, Min Kyoung and Lee, Ji Ye and Ha, Eun Ju and Na, Dong Gyu},
title = {Diagnostic Performance of Ultrasound-Based Risk Stratification Systems for Thyroid Nodules: A Systematic Review and Meta-Analysis},
journal = {Endocrinology and Metabolism},
year = {2023},
volume = {38},
number = {1},
pages = {117--128},
doi = {10.3803/enm.2023.1670}
}
EUVIMED